LENZ Therapeutics, Inc. (LENZ) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $25.18M | +24.9% |
| 2024 | $20.16M | -42.6% |
| 2023 | $35.14M | -26.4% |
| 2022 | $47.73M | -87.3% |
| 2021 | $376.98M | +1805.7% |
| 2020 | $19.78M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $25.18M | +24.9% |
| 2024 | $20.16M | -42.6% |
| 2023 | $35.14M | -26.4% |
| 2022 | $47.73M | -87.3% |
| 2021 | $376.98M | +1805.7% |
| 2020 | $19.78M | — |